Revised Prostate Cancer Screening Guidelines Proposed
THE U.S. PREVENTIVE Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55 to 69 of the potential benefits and harms of prostate-specific...
View ArticleAn Emerging Treatment for Metastatic Prostate Cancer
RESULTS FROM THE VISION TRIAL, first presented at the American Society of Clinical Oncology virtual meeting on June 6, highlighted a treatment called prostate-specific membrane antigen (PSMA) therapy....
View Article
More Pages to Explore .....